Skip to contentL
Lifecore Biomedical, Inc.
L
LFCRLifecore Biomedical, Inc. Q4 2017 · 10-K
Revenue$121.27M$121.27M−10.4% vs Q4 2016 Net Income$2.45M$2.45M−48.1% vs Q4 2016 EPS Diluted$0.09$0.09−47.1% vs Q4 2016 Gross Profit$19,120,000−16.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lifecore Biomedical, Inc. · CIK 1005286 · Engraved from SEC EDGAR
derived
Operating Cash Flowderived-$16,469,000N/M Free Cash Flowderived-$6,858,000N/M Margins · derivedGross margin15.8%−1.1 pt vs Q4 2016
Operating margin1.3%−3.3 pt vs Q4 2016
Net margin2.0%−1.5 pt vs Q4 2016
ended May 28, 2017 · filed Aug 11, 2017 · 75 d after period end